World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
58235
World Ranking
6914
National Ranking
3645

Dong M. Shin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dong M. Shin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 495 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dong M. Shin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dong M. Shin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Dong M. Shin is affiliated with Emory University in the United States and has a research focus primarily in Medicine with significant contributions in Biochemistry, Genetics, and Molecular Biology.

Their research encompasses several specialized subfields, including Oncology, Otorhinolaryngology, Molecular Biology, Pulmonary and Respiratory Medicine, and Surgery. These areas highlight a multidisciplinary approach to medical science, particularly within cancer and respiratory-related studies.

The scientist's work covers a variety of topics notably in Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Cancer-related Gene Regulation, Cancer Diagnosis and Treatment, Epigenetics and DNA Methylation, and Cancer, Hypoxia, and Metabolism.

Some of the recent papers authored or co-authored by Dong M. Shin include:

  • Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer, 2021, Nature
  • Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial, 2023, Nature Medicine
  • Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study, 2021, Cancer
  • Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1, 2021, Nature Communications
  • The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms, 2020, Supportive Care in Cancer

Frequent co-authors reflect long-term collaborative relationships and include:

  • Nabil F. Saba
  • Mihir R. Patel
  • Conor Steuer
  • Kristin Higgins
  • Mark W. McDonald

Shin's research outputs are regularly published in venues such as the International Journal of Radiation Oncology*Biology*Physics and the Journal of Clinical Oncology, each with eight publications. Other notable journals include Clinical Cancer Research with six publications, The Laryngoscope with four, and Cancer Research with four.

Among awards, Dong M. Shin was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2016.

Best Publications

  • Nanoparticle therapeutics: an emerging treatment modality for cancer

    Mark E Davis;Zhuo Georgia Chen;Dong M Shin

  • Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

    James A. Bonner;Paul M. Harari;Jordi Giralt;Nozar Azarnia

  • Therapeutic Nanoparticles for Drug Delivery in Cancer

    Kwangjae Cho;Xu Wang;Shuming Nie;Zhuo Georgia Chen

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

    Marshall R. Posner;Diane M. Hershock;Cesar R. Blajman;Elizabeth Mickiewicz

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Recent Advances in Head and Neck Cancer

    Robert I. Haddad;Dong M. Shin

  • Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

    Rajni Sinha;Gloria J. Kim;Shuming Nie;Dong M. Shin

  • Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.

    J. A. Roth;D. Nguyen;D. D. Lawrence;B. L. Kemp

  • Application of Nanotechnology in Cancer Therapy and Imaging

    Xu Wang;Lily Yang;Zhuo Georgia Chen;Dong M Shin

  • Perspectives for Cancer Prevention With Natural Compounds

    A.R.M. Ruhul Amin;Omer Kucuk;Fadlo R. Khuri;Dong M. Shin

  • Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy.

    Roy S. Herbst M.D.;Dong M. Shin

  • Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

    Stephen G. Swisher;Jack A. Roth;John Nemunaitis;David D. Lawrence

  • Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy

    Xiang-Hong Peng;Ximei Qian;Hui Mao;Andrew Y Wang

  • Cancer prevention with natural compounds.

    Norleena P. Gullett;A. R.M. Ruhul Amin;Soley Bayraktar;John M. Pezzuto

  • Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

    William K. Murphy;Frank V. Fossella;Rodger J. Winn;Dong M. Shin

  • Predicting cancer development in oral leukoplakia: ten years of translational research.

    J. Jack Lee;Waun Ki Hong;Walter N. Hittelman;Li Mao

  • Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

    Roy S. Herbst;Matthew Arquette;Dong M. Shin;Karel Dicke

  • A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands

    Xiaohua Huang;Xiaohua Huang;Xianghong Peng;Yiqing Wang;Yuxiang Wang

  • Dysregulation of Epidermal Growth Factor Receptor Expression in Premalignant Lesions during Head and Neck Tumorigenesis

    Dong M. Shin;Jae Y. Ro;Waun Ki Hong;Walter N. Hittelman

Frequent Co-Authors

Fadlo R. Khuri
Fadlo R. Khuri American University of Beirut
Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
Taofeek K. Owonikoko
Taofeek K. Owonikoko Emory University
Suresh S. Ramalingam
Suresh S. Ramalingam Emory University
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Walter N. Hittelman
Walter N. Hittelman The University of Texas MD Anderson Cancer Center
Shuming Nie
Shuming Nie University of Illinois at Urbana-Champaign
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but seek flexible learning options, online healthcare degrees offer numerous pathways. Many students are drawn to nursing due to growing demand and diverse roles. For aspiring nurses, you can now access accelerated and affordable routes, such as the cheapest online MSN programs and options for those already holding an RN through the cheapest rn to bsn program online.

Non-nurses interested in a rapid transition can explore direct entry nurse practitioner programs for non-nurses online. These innovative programs are tailored for those with bachelor’s degrees in other fields who wish to enter advanced nursing roles efficiently.

For seasoned nurses or educators, advancing knowledge is possible with a phd nursing education online, supporting careers in research, teaching, or leadership. Whether you’re starting in healthcare or progressing your credentials, these online pathways make meaningful medical careers more accessible than ever.

Best Scientists Citing Dong M. Shin

Trending Scientists

Recently Published Articles